Researchers have used large-scale virtual compound libraries, in silico screening and computer simulations to identify small ...

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified endpoint The reduction in GluSph in CSF, a first-ever ...

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...

Addex Therapeutics amends its ATM agreement with HC Wainwright & Company: Geneva, Switzerland Friday, December 12, 2025, 14:30 Hrs [IST] Addex Therapeutics, a clinical-stage bioph ...

New analysis examines RAP-219’s effect during the first month of treatment and consistency of efficacy over the treatment ...

Addex is not obligated to make any sales of ADSs under the ATM Agreement. The Company or H.C. Wainwright & Co. may suspend or ...

The latest announcement is out from Addex Therapeutics ( (CH:ADXN) ).

US AI-focused start-up Formation Bio has entered a deal with Lynk Pharmaceuticals for worldwide rights, excluding Greater ...